Search
- Apr 5
- 3 min
Kryptos Biotechnologies raises $10 million for clinical studies for its point-of-care molecular diagnostics system
Point-of-care testing requires comprehensive requirements in accuracy, speed, cost, and usability
- Mar 29
- 3 min
Clinical-stage oncology company, Boundless Bio prices initial public offering to raise $100 million
Boundless Bio is interrogating extrachromosomal DNA biology to deliver transformative therapies to patients
- Mar 28
- 2 min
IGC Pharma closes $3 Million private placement to advance Alzheimer's treatment
IGC Pharma Inc. (“IGC”) is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness.
- Mar 7
- 4 min
Envoy Medical (NASDAQ: COCH) secures up to $10 million of debt to finance its cochlear implant clinical trial
The Esteem cochlear implant has no externally-worn components required for daily use which allows for “invisible hearing,”
- Mar 1
- 5 min
Kenai Therapeutics closes $82 Million to advance next generation allogeneic cell therapies for neurological diseases, including Parkinson's
The Company utilizes allogeneic induced pluripotent stem cell (iPSC) technology, a Nobel Prize-winning breakthrough